AAOpt 2022: Bausch + Lomb enters the canine healthcare landscape with new Project Watson

Video

Albert Swann share details about Bausch + Lomb's new healthcare product line for dogs: Project Watson.

Albert Swann shares about Baush + Lomb's new line of health care products for dogs, Project Watson, during the 2022 American Academy of Optometry Meeting held in San Diego.

Editor's note: This transcript has been edited for clarity.

I'm Albert Swann for Bausch and Lomb. I'm excited to share with you the launch of Project Watson, healthcare products for dogs.

Project Watson began 3 years ago in my search for eye care solutions for my rescue dog, Watson. And with that—and being a veteran of Bausch and Lomb for over 14 years—I looked internally at the eye health experts of Bausch and Lomb.

We've now developed 6 products to launch for the often overlooked areas of your dog's health: the eyes, the ears, and their overall well-being, with an eyewash an eye wipe, and eye supplements to help support eye health, especially as your dog ages.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.